Full text is available at the source.
Abstract
A detection limit of 0.1 aM was achieved for the BCR1-type PML::RARα fusion using a novel CRISPR/Cas12a-based method.
- Moderate temperature increases improved CRISPR/Cas12a activity while enabling the use of atypical suboptimal protospacer adjacent motifs (PAMs).
- The developed method sensitively identified low-abundance mutant cells in the presence of wild-type cells.
- Efficacy was demonstrated in detecting minimal residual disease samples from patients with relapsed acute promyelocytic leukemia.
- A sensitive approach for detecting L217F single-base mutations reached a detection limit of 10 aM.
- The methods may facilitate the rapid diagnosis of acute promyelocytic leukemia and the detection of low-abundance drug-resistance mutations.
Simplified